Butyrylcholinesterase as a Diagnostic and Therapeutic Target for Alzheimer's Disease

E-ISSN： 1875-5828|13|10|1173-1177

ISSN： 1567-2050

Source： Current Alzheimer Research, Vol.13, Iss.10, 2016-08, pp. : 1173-1177

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Butyrylcholinesterase: a target in the cholinergic treatment of Alzheimer's disease

By Potkin Steven G.

Primary Care Psychiatry, Vol. 9, Iss. 3, 2004-09 ,pp. : 83-87

Informa Healthcare

Access to resources Recommend Favorite

Pyramidal Neurone Modulation: A Therapeutic Target for Alzheimer's Disease

By Francis P.T.

Neurodegeneration, Vol. 5, Iss. 4, 1996-12 ,pp. : 461-465

Academic Press

Access to resources Recommend Favorite

Apolipoprotein E-related neurotoxicity as a therapeutic target for Alzheimer’s disease

By Marques Marcos Crutcher Keith

Journal of Molecular Neuroscience, Vol. 20, Iss. 3, 2003-08 ,pp. : 327-337

Humana Press, Inc

Access to resources Recommend Favorite

Therapeutic approaches to Alzheimer's disease

By Klafki Hans-Wolfgang Staufenbiel Matthias Kornhuber Johannes Wiltfang Jens

Brain, Vol. 129, Iss. 11, 2006-11 ,pp. : 2840-2855

Oxford University Press

Access to resources Recommend Favorite

p38 Mitogen Activated Protein Kinase as a Therapeutic Target for Alzheimer’s Disease

By Dalrymple Stacie A.

Journal of Molecular Neuroscience, Vol. 19, Iss. 3, 2002-12 ,pp. : 295-300

Humana Press, Inc

Access to resources Recommend Favorite